A commercial stage pharmaceutical company with three revenue generating pharmaceutical products
A commercial stage pharmaceutical company with three revenue generating pharmaceutical products
Development pipeline targeting large medical needs
AmorphOX® - a novel world leading nasal delivery technology leading to a new wave of products
NOVEMBER 30, 2023
Interview with Robert DeLuca, President of Orexo US Inc. on the OUD market and expanding the product portfolio
NOVEMBER 28, 2023
FDA has accepted the New Drug Application filing for OX124
NOVEMBER 2, 2023
Orexo Q3 2023 Interim Report